How healthcare must respond to ventilator-associated pneumonia (VAP) in invasively mechanically ventilated COVID-19 patients - 09/10/21
Doi : 10.1016/j.ajem.2021.01.074
Lukasz Szarpak, PhD, MBA c 
, Jonathan Wisco, PhD a, ⁎ , Richard Boyer, PhD, MD b
, Jonathan Wisco, PhD a, ⁎ , Richard Boyer, PhD, MD b a Department of Anatomy and Neurobiology, Laboratory for Translational Anatomy of Degenerative Diseases and Developmental Disorders (TAD4), Boston University School of Medicine, Boston, MA, USA
b Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA
c Maria Sklodowska-Curie Bialystok Oncology Center, Bialystok, Poland
⁎Corresponding author at: Department of Anatomy and Neurobiology, Laboratory for Translational Anatomy of Degenerative Diseases and Developmental Disorders (TAD4), Boston University School of Medicine, 72 E Concord St, L-1004, Boston, MA 02118, USA.Department of Anatomy and NeurobiologyLaboratory for Translational Anatomy of Degenerative Diseases and Developmental Disorders (TAD4)Boston University School of Medicine72 E Concord StL-1004BostonMA02118USA
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Ventilator-associated pneumonia, Tracheal intubation, Subglottic secretion drainage, Suction-above-cuff, COVID-19, SARS-CoV-2
Le texte complet de cet article est disponible en PDF.
© 2021
Publié par Elsevier Masson SAS.
Vol 48
P. 361-362 - octobre 2021 Retour au numéro
Article précédent
- COVID-19 in patients with cancer: Risks and precautions
- AzadehSadat Razavi, Michael R. Hamblin, Nima Rezaei
- Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions
- Haley Ehrlich, Adel Elkbuli
Bienvenue sur EM-consulte, la référence des professionnels de santé.